Healthcare >> CEO Interviews >> March 8, 2004

KEVIN RAKIN – GENAISSANCE PHARMACEUTICALS INC (GNSC)

KEVIN RAKIN is President and Chief Executive Officer of Genaissance Pharmaceuticals, Inc. He is a member of the Board of Directors and a Founder of the company. He was appointed Chief Executive Officer, in addition to President, in August 2002 and previously served as the company's President and Chief Financial Officer. Mr. Rakin was previously a Principal at The Stevenson Group where he provided investment, strategic and merchant banking services to high-growth technology companies and venture capital firms. From 1982 to 1990, he was associated with Ernst and Young and served as a Manager in the Entrepreneurial Services Group. Mr. Rakin is co-Chairman of the Board of Directors of Connecticut United For Research Excellence (CURE), Connecticut's BioScience Cluster. He is also on the Board of Directors of the MIT Enterprise Forum of Connecticut, Inc. Mr. Rakin received a BS in Business and an MS in Finance from the University of Cape Town and an MBA from Columbia University. Profile
TWST: What is Genaissance Pharmaceuticals, Inc.?

Mr. Rakin: Genaissance's principal business is focused on integrating

genetic variation into a new generation of more targeted therapeutic